Lu, Min <br/><br/>
A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.  [electronic resource] 

 -  American journal of physiology. Endocrinology and metabolism  May 2010 
 - E1036-48 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1555 
<br/><br/><label>Standard No.: </label>10.1152/ajpendo.00668.2009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analysis of Variance<br/>Animals<br/>Blood Glucose--metabolism<br/>Blotting, Western<br/>Cell Movement--drug effects<br/>Chemokines--metabolism<br/>Cytokines--metabolism<br/>Dehydroepiandrosterone--analogs & derivatives<br/>Female<br/>Gene Expression<br/>Gluconeogenesis--drug effects<br/>Glucose Clamp Technique<br/>Glucose Tolerance Test<br/>Humans<br/>Immunohistochemistry<br/>Inflammation--drug therapy<br/>Insulin Resistance<br/>Lipids--blood<br/>Lipopolysaccharides<br/>Liver--drug effects<br/>Macrophages--drug effects<br/>Male<br/>Mice<br/>Middle Aged<br/>Muscle, Skeletal--drug effects<br/>Obesity--drug therapy<br/>Rats<br/>Rats, Zucker